Research & Pharmaceutical
4301 Connecticut Ave, NW
Suite 330
Washington, DC
USA 20008
Email: tami.mark@thomsonreuters.com
Disclosure statement:
Qualified on the content I am responsible for because: I have given many many presentations on the topic of substance abuse services and medications to treat substance abuse
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.